Company Filing History:
1 out of 200 
1 out of 37 Years Active: 1994
Title: The Innovations of Hideya Tsuge
Introduction
Hideya Tsuge is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. His work focuses on novel compounds that enhance the efficacy and safety of vaccines.
Latest Patents
Hideya Tsuge holds 1 patent for his invention related to muramyldipeptide derivatives. His patent includes innovative compounds such as [6-0-(2-tetradecylhexadecanoyl)-N-acetylmuramoyl]-L-alanyl-D-glutamamide and [6-0-(2-tetradecylhexadecanoyl)-N-acetylmuramoyl]-L-alanyl-N-methyl-D-glutamamide. These muramyldipeptide derivatives serve as excellent adjuvants or components of virosome vaccines. The influenza vaccine developed using these derivatives demonstrates remarkable antibody-producing capacity and safety.
Career Highlights
Throughout his career, Hideya Tsuge has worked with prominent organizations, including Daiichi Pharmaceutical Co., Ltd. and the Chemo-Sero-Therapeutic Research Institute. His experience in these companies has allowed him to contribute significantly to pharmaceutical research and development.
Collaborations
Hideya Tsuge has collaborated with esteemed colleagues such as Masaharu Oki and Kunio Ohkuma. These partnerships have furthered his research and innovation in the field of vaccine technology.
Conclusion
Hideya Tsuge's contributions to vaccine development, particularly through his innovative muramyldipeptide derivatives, highlight his importance in the field of immunology. His work continues to influence the safety and efficacy of influenza vaccines.